PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...
Eric Linsley will co-chair the CED's 25th Annual Venture Conference in Durham, NC
News | 04. 16. 2008
